Future Outlook of the Rubella Diagnostic Testing Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the rubella diagnostic testing market size evolved in recent years?
The rubella diagnostic testing market has expanded significantly, expected to grow from $1.3 billion in 2024 to $1.39 billion in 2025, with a CAGR of 6.9%. Growth in the historic period is attributed to the rise in vaccination programs, increasing immunization-preventable outbreaks, government efforts to control rubella, and broader diagnostic testing availability.
What are the predictions for the rubella diagnostic testing market size in the coming years?
The rubella diagnostic testing market is projected to expand steadily, reaching $1.79 billion by 2029 at a CAGR of 6.5%. Growth is driven by rising healthcare expenditure, increasing focus on preventive care, greater awareness of vaccine-preventable diseases, expanding public health campaigns, and the growth of telemedicine and remote diagnostics. Key trends include advancements in diagnostic technology, integration of healthcare systems with digital tools, development of point-of-care solutions, new diagnostic methods, and innovations in molecular diagnostics.
Get your rubella diagnostic testing market report here!
https://www.thebusinessresearchcompany.com/report/rubella-diagnostic-testing-global-market-report
What key factors are fueling the growth of the rubella diagnostic testing market?
The increasing prevalence of viral infections is anticipated to drive the growth of the rubella diagnostic testing market. These infections, caused by viruses that replicate inside living cells, are spreading due to factors like increased global travel and climate change. Rubella diagnostic testing helps detect infections early, preventing complications, especially for pregnant women, and controls the virus’s spread. In December 2023, the National Health Service reported significant rises in flu and norovirus cases, indicating a higher occurrence of viral infections, thus supporting the growth of the rubella diagnostic testing market.
How is the global rubella diagnostic testing market divided into key segments?
The rubella diagnostic testingmarket covered in this report is segmented –
1) By Diagnostic Technique: Latex Agglutination, Liver Function Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques
2) By Age Group: Neonates, Teenagers, Adults
3) By End User: Hospitals And Clinics, Cancer Diagnostic Centers, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Latex Agglutination: Qualitative Latex Agglutination Tests, Quantitative Latex Agglutination Tests, Rapid Latex Agglutination Kits
2) By Liver Function Tests: Serum Bilirubin Tests, Alanine Aminotransferase (ALT) Tests, Aspartate Aminotransferase (AST) Tests, Alkaline Phosphatase (ALP) Tests, Other Liver Enzyme Tests
3) By Enzyme Immunoassay (EIA): Direct EIA, Indirect EIA, Sandwich EIA, Competitive EIA
4) By Radioimmunoassay (RIA): Standard RIA, Modified RIA, Single-Antibody RIA
5) By Fluorescent Immunoassay (FIA): Direct FIA, Indirect FIA, Sandwich FIA
6) Other Diagnostic Techniques: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAAT), Microplate-Based Assays, Western Blotting
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19177&type=smp
Who are the key firms paving the way for growth in the rubella diagnostic testing market?
Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH
Which trends are expected to transform the rubella diagnostic testing market?
Firms that are key players in the rubella diagnostic testing market are concentrating their efforts on creating new solutions like a rubella virus vaccine to ameliorate diagnostic precision and enhance preventive efforts. This particular vaccine offers protection against rubella and is often included in the MMR or MMRV combo vaccines as a measure against the disease and its associated complications. For instance, in March 2023, the American pharmaceutical firm, Merck & Co., Inc., gained FDA authorization for their M-M-R II vaccine to be administered intramuscularly (IM). This vaccine is integral to rubella protection, in addition to delivering immunity against measles and mumps. This approval facilitates healthcare providers administering the rubella vaccine via the IM pathway, aligning it with other pediatric vaccines that are recommended on a regular basis. It’s crucial to have rubella vaccination to prevent outbreaks and shield against severe complications that can arise from the virus, particularly amongst expectant mothers.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19177
What regions are contributing significantly to the growth of the rubella diagnostic testing market?
North America was the largest region in the rubella diagnostic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Influenza Diagnostic Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report
Application Testing Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/application-testing-services-global-market-report
Bone and Mineral Diagnostic Testing Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: